White Oak Capital - Pharma and Healthcare Fund · Regular · Growth
NAV
₹16.5030
as of 30 Sept 2026
Expense Ratio
2.37%
AUM
₹642 Cr
Lumpsum returns (CAGR)
- 1Y
- +22.05%
- 3Y
- —
- 5Y
- —
- Since Inception
- +20.83%
SIP returns (XIRR)
- 1Y
- +25.69%
- 3Y
- —
- 5Y
- —
- Since Inception
- +19.66%
Returns calculated from 16 January 2024 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
We don't show backtest scenarios for this fund yet — its NAV history has an unresolved discontinuity we're still verifying. Returns above are unaffected.
Risk Metrics
Trailing 1 year, annualised1.28
Sharpe Ratio
+0.21
Alpha
0.17
Beta
1.29
Sortino
12.78%
Std Dev
-9.51%
Max Drawdown
Performance Comparison
Related reading
Thinking about White Oak Capital - Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
What this fund does
White Oak Capital - Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
White Oak Capital - Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by WhiteOak Capital Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹642 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.37%.